Health ❯ Healthcare ❯ Clinical Trials

Phase 1 Trials

Vaccine Trials Antibody-Drug Conjugates Brainshuttle AD Study ARC-20 Trial CAR T-cell Therapy Phase 1b Studies Vaccine Efficacy Cancer Vaccines CD40 Agonist Antibodies Targeted Therapy Trials CAR T-cell Therapy Trials CAR-T Cell Therapy SGNB6A-001 Trial HIV Vaccine Trials 2141-V11 Drug Chronic Weight Management Multiple Myeloma Trials SGT-212 DeLLphi-303 Trial Myelofibrosis Treatments Vaccine ELI-002 2P FURTHER Trial Drug Efficacy Beamion LUNG-1 Trial Personalized Medicine Investigational Therapies mRNA Therapy Trials Elderly Adults EBC-129 Trial Results Experimental Therapies FUMANBA-1 Trial Oculopharyngeal Muscular Dystrophy Safety and Efficacy Elironrasib Trials DeLLphi-303 Study BNT116 Vaccine Drug Safety WEE1/PKMYT1 Inhibitors Phase 2 Studies

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

The deal gives Lilly a Type II JAK2 drug that aims to help patients who stop responding to today’s JAK2 therapies.

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

UNM Launches Phase 1a/1b Trial of Tau-Targeting Alzheimer’s Vaccine